As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.
7 Analysts have issued a BeyondSpring Inc. forecast:
7 Analysts have issued a BeyondSpring Inc. forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -13 -13 |
-
|
|
| EBIT (Operating Income) EBIT | -13 -13 |
41%
41%
|
|
| Net Profit | -8.45 -8.45 |
70%
70%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
BeyondSpring, Inc. is a clinical stage company, which engages in the development of cancer therapies. It focuses on non-small cell lung cancer, neutropenia prevention, and plinabulin and nivolumab. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.
| Head office | Cayman Islands |
| CEO | Lan Huang |
| Employees | 40 |
| Founded | 2010 |
| Website | www.beyondspringpharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


